Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Xiaomin Cen"'
Autor:
You Li, Zhenan Deng, Junjie Wen, Changxing Ou, Xiaomin Cen, Yongkang Liao, Qingling Zhang, Jiaxing Xie
Publikováno v:
Annals of Medicine, Vol 56, Iss 1 (2024)
AbstractObjective Dupilumab has been approved for the treatment of severe asthma with type 2 inflammation by inhibiting interleukin (IL)-4 and IL-13 signaling. However, dupilumab-induced hypereosinophilia (HE) has been reported and should not be igno
Externí odkaz:
https://doaj.org/article/9d34b8a72c1e4789958273d128319a93
Autor:
Zhenan Deng, Xuefei Zhang, Junjie Wen, Xiaojing Yang, Lingna Xue, Changxing Ou, Jianjuan Ma, Hongrui Zhan, Xiaomin Cen, Xuliang Cai, Yu Zhang, Riken Chen, Qingling Zhang
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Eosinophilic asthma is the predominant phenotype of asthma, and although these patients are sensitive to glucocorticoid therapy, they also experience many side effects. Lonicerin is a kind of bioflavonoid isolated from the Chinese herb Lonicera japon
Externí odkaz:
https://doaj.org/article/5e0b768a77ae48208b5337afb0e6b352
Publikováno v:
Clinical and Developmental Immunology, Vol 2013 (2013)
Objective. To analyze serum interleukin-6 (IL-6) expression level and its clinical significance in patients with dermatomyositis. Methods. Blood samples from 23 adult patients with dermatomyositis (DM), 22 with systemic lupus erythematosus (SLE), 22
Externí odkaz:
https://doaj.org/article/0c6e769b36af481a913208cd253eb648
Publikováno v:
Clinical and Developmental Immunology, Vol 2013 (2013)
Interstitial lung disease (ILD) is a common and severe complication of idiopathic inflammatory myopathies (IIM). The aim of our study was to identify risk factors for ILD by evaluating both clinical and biochemical features in IIM patients with or wi
Externí odkaz:
https://doaj.org/article/7fdbe1ed02f8431b84cb39da2c0f3a88
Autor:
Zhenan Deng, Xuefei Zhang, Junjie Wen, Xiaojing Yang, Lingna Xue, Changxing Ou, Jianjuan Ma, Hongrui Zhan, Xiaomin Cen, Xuliang Cai, Yu Zhang, Riken Chen, Qingling Zhang
Publikováno v:
Frontiers in Pharmacology; 12/23/2022, Vol. 13, p1-14, 14p